Skip to main content
Premium Trial:

Request an Annual Quote

Quest to Use CollabRx's Genetic Variant Annotation Services in NGS Testing

NEW YORK (GenomeWeb) – Data analytics firm CollabRx has inked a non-exclusive deal with Quest Diagnostics to provide the company with its medical annotation services.

Under the agreement, Quest will have access to medical content services from CollabRx, such as scientific literature, medical guidelines, and published therapeutic protocols. The services, marketed as Genetic Variant Annotation, were developed by CollabRx but customized by Quest.

Doctors that use Quest's next-generation sequencing services to perform genetic analysis on cancer patients will have access to this medical content to help them guide treatment strategies. “The annotated content may help physicians better understand, through the database, the clinical significance of test results indicating the presence of one or more gene mutations,” CollabRx said in a statement, highlighting that Quest each year serves approximately half the physicians and hospitals in the US.

As part of the deal, Quest can also use CollabRx content to inform clinical trials that it is performing with drug developers and other partners.

The firms did not disclose additional details of their agreement.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.